title: Muscle weakness after administration of neuromuscular blocking agents: do not immobilize the diaphragm unnecessarily.
authors.forename: Matthias
authors.initials: M
authors.lastname: Eikermann
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Chamberlin
authors.forename: Helmut
authors.initials: H
authors.lastname: Gerber
authors.forename: Atul
authors.initials: A
authors.lastname: Malhotra
mesh_terms: D000732:Androstanols / Q000009:adverse effects*; D000818:Animals; D003964:Diaphragm / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D009133:Muscular Atrophy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D051381:Rats; D012121:Respiration, Artificial / Q000009:adverse effects*; D000077123:Rocuronium
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D000077123:Rocuronium